Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for classic stiff person syndrome has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for classic stiff person syndrome.
8 publications have been identified in PubMed for classic stiff person syndrome. Research spans Case Report / Case Series (38%), Diagnostic / Biomarker (25%), and Epidemiology / Natural History (25%).
Queisi MM (2025). [PMID: 40776531](https://pubmed.ncbi.nlm.nih.gov/40776531/). *Annals of clinical and translational neurology*. [Diagnostic / Biomarker]
Krett JD (2025). [PMID: 40342250](https://pubmed.ncbi.nlm.nih.gov/40342250/). *European journal of neurology*. [Epidemiology / Natural History]
Roy S (2025). [PMID: 40323494](https://pubmed.ncbi.nlm.nih.gov/40323494/). *Journal of neurology*. [Diagnostic / Biomarker]
Roman SN (2025). [PMID: 41180121](https://pubmed.ncbi.nlm.nih.gov/41180121/). *Therapeutic advances in neurological disorders*. [Gene Therapy / Novel Therapeutics]
Ikechukwu C (2025). [PMID: 40852673](https://pubmed.ncbi.nlm.nih.gov/40852673/). *Annals of Ibadan postgraduate medicine*. [Case Report / Case Series]
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 1:12 PM UTC
Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about classic stiff person syndrome
Anusha M (2024). [PMID: 39122374](https://pubmed.ncbi.nlm.nih.gov/39122374/). *BMJ case reports*. [Case Report / Case Series]
Wang Y (2024). [PMID: 38078976](https://pubmed.ncbi.nlm.nih.gov/38078976/). *Journal of neurology*. [Epidemiology / Natural History]
Quintal-Medina IA (2024). [PMID: 39372829](https://pubmed.ncbi.nlm.nih.gov/39372829/). *AACE clinical case reports*. [Case Report / Case Series]
AI-curated news mentioning classic stiff person syndrome
Updated Jul 29, 2026
A recent study investigates exteroceptive reflexes in patients with stiff person syndrome compared to other neurological conditions and healthy controls. This research may provide insights into the underlying mechanisms of reflex responses in rare neurological disorders.
Kyverna Therapeutics presents promising Phase 1 data for Miv-cel in Stiff Person Syndrome, showing 66.6% ACR70 response at Week 36 without high-grade CRS or ICANS. This data supports Miv-cel's potential to transform treatment for autoimmune diseases.
Kyverna's CAR-T therapy for stiff person syndrome is approaching approval, addressing a significant unmet need in treating this rare condition. Currently, there is only one other noteworthy therapy in clinical trials, highlighting the urgency for effective treatments.
A recent case series published in PubMed highlights the significant autoimmune overlap between Sjögren's disease and Stiff Person Syndrome. This research underscores the need for increased awareness and understanding of these rare conditions.